---
title: "Roivant Sciences reports Q3 results"
date: "2025-02-10 16:43:06"
summary: "Roivant Sciences press release  (NASDAQ:ROIV): Q3 EPS of $0.23 may not be comparable to consensus of -$0.24. Revenue of $9.02M (-75.7% Y/Y) As of December 31, 2024, the company had consolidated cash, cash equivalents, restricted cash, and marketable securities of approximately $5.2 billion."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Roivant Sciences [press release](https://investor.roivant.com/news-releases/news-release-details/roivant-reports-financial-results-third-quarter-ended-december-0) (NASDAQ:[ROIV](https://seekingalpha.com/symbol/ROIV "Roivant Sciences Ltd.")): Q3 EPS of $0.23 may not be comparable to consensus of -$0.24.
* Revenue of $9.02M (-75.7% Y/Y)
* As of December 31, 2024, the company had consolidated cash, cash equivalents, restricted cash, and marketable securities of approximately $5.2 billion.

[seekalpha](https://seekingalpha.com/news/4405577-roivant-sciences-reports-q3-results)
